Investment, Funding & Disinvestments

The new hospital forms a central pillar of a wider specialised medical city focused on women and children’s health.

The donation includes 108 electric obstetric theatre beds, along with specialised equipment for women’s cancer screening, diagnosis, and treatment.

Under the new system, Emiratis will be able to access healthcare services anywhere in the country regardless of their emirate of residence.

Under the agreement, Lilly will obtain exclusive worldwide rights, excluding South Korea, to develop, manufacture, and commercialise sonefpeglutide, a long-acting GLP-2 analogue.

Under the agreement, Servier will take control of Edgewise Therapeutics’ muscular dystrophy portfolio, including its lead candidate sevasemten.

The partnership introduces a new model of care that combines advanced remote monitoring, post-discharge support, and hospital-at-home services, allowing patients to remain connected to healthcare professionals throughout their recovery journey.

The initiative focuses on expanding genomic sequencing capacity, improving molecular diagnostics, and enhancing real-time disease surveillance across African health systems.

The financing will also reinforce critical pillars of outbreak control, including disease surveillance, laboratory diagnostics, infection prevention and control, and cross-border coordination mechanisms.

Established in 2022, the collaboration combines CytomX’s Probody masking technology with Regeneron’s Veloci-Bi bispecific antibody platform.

The plan follows Arada’s acquisition of a controlling stake in Reem Hospital, marking the company’s entry into the healthcare sector as it expands its presence across non-residential industries.